These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37647825)

  • 1. Indications for the use of intravenous second-line antiseizure medications in an emergency room setting.
    Pöytäkangas T; Saarinen JT; Basnyat P; Rainesalo S; Peltola J
    Epilepsy Res; 2023 Oct; 196():107218. PubMed ID: 37647825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.
    Takeuchi H; Higurashi N; Toga Y
    Brain Dev; 2024 Jun; 46(6):219-223. PubMed ID: 38519270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
    Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
    CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral Long-Acting Antiseizure Medications Are Used More Often to Treat Seizure Clusters Than Convulsive Status Epilepticus in the Pediatric Emergency Department.
    Pfeiffer CK; Mackay MT; Long E; Stephens D; Dalziel SR; Babl FE;
    J Child Neurol; 2022 Jun; 37(7):589-598. PubMed ID: 35142572
    [No Abstract]   [Full Text] [Related]  

  • 5. Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience.
    Llauradó A; Campos D; Quintana M; Ballvé A; Fonseca E; Abraira L; Giffreu A; Toledo M; Santamarina E
    Epilepsy Res; 2022 Sep; 185():106988. PubMed ID: 35907324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two-year prospective surveillance study.
    Meyer S; Langer J; Poryo M; Bay JG; Wagenpfeil S; Heinrich B; Nunold H; Strzelczyk A; Ebrahimi-Fakhari D
    Epilepsia Open; 2023 Jun; 8(2):411-424. PubMed ID: 36764666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing nonconvulsive status epilepticus: Defining electroencephalographic and clinical response to diagnostic intravenous antiseizure medication trials.
    Leitinger M; Gaspard N; Hirsch LJ; Beniczky S; Kaplan PW; Husari K; Trinka E
    Epilepsia; 2023 Sep; 64(9):2351-2360. PubMed ID: 37350392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus.
    Bravo P; Vaddiparti A; Hirsch LJ
    Drugs; 2021 May; 81(7):749-770. PubMed ID: 33830480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCSE-coma in older adults: Clinical data, initial EEG, and hospital outcome.
    Tedrus GMAS
    Epilepsy Behav; 2024 Sep; 158():109929. PubMed ID: 39002275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of seizure clusters and status epilepticus following rapid and ultra-rapid medication discontinuation during intracranial EEG monitoring.
    Malgireddy K; Gupta N; Baang HY; Samson KK; Madhavan D; Puccioni M; Taraschenko O
    Epilepsy Res; 2021 Nov; 177():106756. PubMed ID: 34543831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent antiseizure medications in the Intensive Care Unit.
    Orinx C; Legros B; Gaspard N
    Minerva Anestesiol; 2017 Aug; 83(8):878-887. PubMed ID: 28492297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-convulsive status epilepticus in the setting of cannabidiol adjunctive therapy.
    Tanwir A; Szabó CÁ
    Epileptic Disord; 2022 Aug; 24(4):713-718. PubMed ID: 35770762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Antiseizure Medications in Wolf-Hirschhorn Syndrome.
    Horiguchi A; Koichihara R; Kikuchi K; Nonoyama H; Daida A; Oba D; Hirata Y; Matsuura R; Ohashi H; Hamano SI
    Neuropediatrics; 2023 Oct; 54(5):339-343. PubMed ID: 37075791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous lacosamide for acute repetitive seizures and convulsive status epilepticus in critically ill children.
    Hsiao MR; Tsai TC; Hsia SH; Chan OW; Lee EP; Lin JJ; Lin KL
    Epilepsia Open; 2024 Dec; 9(6):2241-2250. PubMed ID: 39254674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous brivaracetam for the management of refractory focal non-convulsive status epilepticus.
    Ammar AA; Ammar MA; Owusu K; Gilmore EJ
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
    Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
    Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of benzodiazepine-refractory status epilepticus: A retrospective, cohort study.
    Rollo E; Romozzi M; Dono F; Bernardo D; Consoli S; Anzellotti F; Ricciardi L; Paci L; Sensi SL; Della Marca G; Servidei S; Calabresi P; Vollono C
    Epilepsy Behav; 2023 Mar; 140():109093. PubMed ID: 36739634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
    Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
    Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.